The Adult Stem Cell Research Network
Monday, 30 June 2008 15:54
The Adult Stem Cell Research (ASCR) Network is an Internet-based project of The Cell Therapy Foundation designed to be a well-maintained and reliable source of information for the public regarding adult stem cell research, as well as to be a community of practice and collaboration among fellow researchers. The ASCR Network publishes the latest scientific news in the adult stem cell arena, identifies the leading researchers in the field, and locates key clinical trials; as well as connects the global community of adult stem cell researchers with one another. Since its launch in the winter of 2007, over 100 news articles have been published giving valuable insight into the ever expanding world of adult stem cell research. The ASCR Network also has extensive information on 24 labs doing research on adult stem cells. In the near future, the network will host a comprehensive list of ongoing clinical trials where the general public can search for a clinical trial by area or ailment allowing the public to more easily find hope for possible relief from their ailment and researchers to more easily complete their trials. The faster researchers are able to complete their investigations, the more swiftly cures for diseases such as diabetes, heart disease and Alzheimer's will be discovered.
 


Get Involved

Don’t let adult stem cell research become idle and delay the potential to improve lives around the world. To support our mission please DONATE HERE.

Newsletter Sign Up
Contact Form
Research Network

The Web-based Adult Stem Cell Research (ASCR) Network exists to encourage and support global collaboration among adult stem cell scientists and match patients with clinical trials. Worldwide membership includes laboratories in Brazil, France, The Netherlands, Singapore, South Korea, Sweden, Taiwan, and USA.

Visit www.ascrnetwork.org

Success Stories

“I hope that someday when I see an older person having trouble with their leg(s), faced with the same problem I had, they have this revolutionary therapy available for them because of the chance I took as a clinical trial patient.”
Jacque Pentell